107 related articles for article (PubMed ID: 12708965)
1. Reduction in hepatic endothelin-1 clearance in cirrhosis.
Tran Duc AT; Schwab AJ; Simard A; Villeneuve L; Dupuis J
Clin Sci (Lond); 2003 Aug; 105(2):227-34. PubMed ID: 12708965
[TBL] [Abstract][Full Text] [Related]
2. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
Rockey DC; Weisiger RA
Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
[TBL] [Abstract][Full Text] [Related]
3. Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.
Kamath PS; Carpenter HA; Lloyd RV; McKusick MA; Steers JL; Nagorney DM; Miller VM
Liver Transpl; 2000 Sep; 6(5):596-602. PubMed ID: 10980059
[TBL] [Abstract][Full Text] [Related]
4. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
5. Expression of endothelin-1, and endothelin A and B receptors in portal hypertensive esophagus of rats.
Ohta M; Pai R; Kawanaka H; Ma T; Sugimachi K; Sarfeh IJ; Tarnawski AS
J Physiol Pharmacol; 2000 Mar; 51(1):57-67. PubMed ID: 10768851
[TBL] [Abstract][Full Text] [Related]
6. [Effects of ET-1 on isolated perfused rat liver and vascular rings at two stages of cirrhosis].
Yao D; Yao X; Yang C; Feng Z; Fang H; Gao J
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1565-8. PubMed ID: 12609069
[TBL] [Abstract][Full Text] [Related]
7. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
Gandhi CR; Nemoto EM; Watkins SC; Subbotin VM
Liver; 1998 Feb; 18(1):39-48. PubMed ID: 9548266
[TBL] [Abstract][Full Text] [Related]
8. The endothelin-1 receptor-mediated pathway is not involved in the endothelin-1-induced defenestration of liver sinusoidal endothelial cells.
Yokomori H; Yoshimura K; Ohshima S; Nagai T; Fujimaki K; Nomura M; Oda M; Hibi T
Liver Int; 2006 Dec; 26(10):1268-76. PubMed ID: 17105593
[TBL] [Abstract][Full Text] [Related]
9. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
Callaghan R; Desmond PV; Paull P; Mashford ML
Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
[TBL] [Abstract][Full Text] [Related]
10. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
Fenyves D; Gariépy L; Villeneuve JP
Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Thirunavukkarasu C; Yang Y; Subbotin VM; Harvey SA; Fung J; Gandhi CR
Gut; 2004 Jul; 53(7):1010-9. PubMed ID: 15194653
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats.
Gandhi CR; Sproat LA; Subbotin VM
Life Sci; 1996; 58(1):55-62. PubMed ID: 8628111
[TBL] [Abstract][Full Text] [Related]
13. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
[TBL] [Abstract][Full Text] [Related]
14. [Distribution and significance of endothelin-1 and endothelin receptor a mRNA in liver after endotoxemia].
Liu B; Chen H; Wang D
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):171-4. PubMed ID: 9596952
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1, endothelin A and B receptor expression and their pharmacological properties in GFAP negative human lamina cribrosa cells.
Rao VR; Krishnamoorthy RR; Yorio T
Exp Eye Res; 2007 Jun; 84(6):1115-24. PubMed ID: 17433294
[TBL] [Abstract][Full Text] [Related]
16. Accelerated reversal of carbon tetrachloride-induced cirrhosis in rats by the endothelin receptor antagonist TAK-044.
Anselmi K; Subbotin VM; Nemoto E; Gandhi CR
J Gastroenterol Hepatol; 2002 May; 17(5):589-97. PubMed ID: 12084034
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
[TBL] [Abstract][Full Text] [Related]
18. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.
Shibamoto T; Kamikado C; Koyama S
Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271
[TBL] [Abstract][Full Text] [Related]
19. Arterialization of the portal vein improves hepatic microcirculation and tissue oxygenation in experimental cirrhosis.
Yang W; Koti R; Glantzounis G; Davidson BR; Seifalian AM
Br J Surg; 2003 Oct; 90(10):1232-9. PubMed ID: 14515292
[TBL] [Abstract][Full Text] [Related]
20. Functional link between ETB receptors and eNOS maintain tissue oxygenation in the normal liver.
Paxian M; Keller SA; Baveja R; Korneszczuk K; Huynh TT; Clemens MG
Microcirculation; 2004; 11(5):435-49. PubMed ID: 15280069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
